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Electrical Stimulation Enhances Epidermal
Proliferation in Human Cutaneous Wounds by
Modulating p53–SIVA1 Interaction
Anil Sebastian1, Syed A. Iqbal1, James Colthurst2, Susan W. Volk3 and Ardeshir Bayat1,4,5
Cutaneous wounds establish endogenous ‘‘wound current’’ upon injury until re-epithelialization is complete.
Keratinocyte proliferation, regulated partly by p53, is required for epidermal closure. SIVA1 promotes human
double minute 2 homolog (HDM2)–mediated p53 regulation. However, the role of SIVA1 in wound healing is
obscure. Here, we report that electrical stimulation (ES) accelerates wound healing by upregulating SIVA1 and its
subsequent ability to modulate p53 activities. Cultured donut-shaped human skin explants, subjected to ES,
exhibited better epidermal stratification, increased proliferation, and upregulation of gene and protein
expression of HDM2/SIVA1, compared with non-ES-treated explants. ES significantly increased in vitro keratino-
cyte proliferation and phospho-p53–SIVA1 interaction; however, this showed stable expression of phospho-p53,
which increased significantly in the absence of SIVA1. Here, HDM2 alone was unable to downregulate nuclear-
accumulated phospho-p53, which was evident from decreased proliferation and increased sub-G1 population
seen by flow cytometry. Further examination of the epidermis of human cutaneous wounds showed higher
p53–SIVA1 coexpression and proliferation 7 days after injury in ES-treated wounds compared with control
wounds. In summary, ES-inducible SIVA1 modulates p53 activities in proliferating keratinocytes, and exogenous
ES affects p53/HDM2/SIVA1 axis leading to increased proliferation during re-epithelialization. This highlights ES as
a potential strategy for enhancing cutaneous repair.
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INTRODUCTION
Upon injury to the epithelium, an endogenous transepithelial
potential drives current away from low-resistance regions
(Nuccitelli, 2003) and results in the generation of a lateral
electric field (wound current; Nuccitelli et al., 2008) within
the epidermis. Therefore, the rationale for exogenous
application of electrical stimulation (ES) is to mimic the
in vivo bioelectric system or to augment the endogenous
wound current that promotes the wound healing process.
However, precise mechanisms by which ES promotes tissue
repair remain poorly defined.
The role of exogenous ES in accelerating re-epithelialization
has been associated with cell migration (Nishimura et al.,
1996; Ojingwa and Isseroff, 2003; Jennings et al., 2010).
However, the exact role of cell proliferation has not been
investigated in relation to ES and re-epithelialization, despite
the fact that normal healing requires keratinocyte proliferation
during re-epithelialization (Amar and Wu, 2014). In
mammalian cells, p53 tumor suppressor activates
antiproliferative processes in response to stress such as DNA
damage (Vogelstein et al., 2000; Vousden and Lane, 2007).
Temporal expression of p53 in wound healing has been
investigated primarily in experimental animal models with a
paucity of data available for human epithelial healing
(Antoniades et al., 1994). In vitro data suggest that the
maximal expression of p53 occurs in proliferating
keratinocytes (Dazard et al., 2000). Recently, it has been
shown that mild ES induces p53 phosphorylation via p38
mitogen-activated protein kinase signaling and G2 cell cycle
arrest without apoptosis (Fukuda et al., 2013).
The activation of p53 induces the expression of downstream
genes such as SIVA1 and human double minute 2 (HDM2),
which further regulate apoptosis and cell cycle progression
(Chen et al., 1994; Beckerman and Prives, 2010). SIVA1 has
been identified to have both antiapoptotic (Du et al., 2010)
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and proapoptotic roles through multiple signaling pathways
(Chu et al., 2004; Resch et al., 2009), whereas HDM2 has
been shown to act as the principal p53 antagonist (E3 ligase
for p53) and it limits the duration and intensity of p53
activation (Michael and Oren, 2003). In normal/unstressed
cells, SIVA1 promotes p53-HDM2 interaction, thereby
enhancing p53 ubiquitination and degradation without
affecting the stability of HDM2 (Du et al., 2010).
The ability of human keratinocytes to upregulate prolifera-
tion-related subunits while simultaneously increasing p53 and
HDM2 expressions has been shown previously (Flatt et al.,
1998). In one study, instead of directly affecting p53 protein
levels, the downstream target genes of p53 including those for
apoptosis were significantly reduced (transcriptional
repression) by overexpressing HDM2 (Ohkubo et al., 2006).
However, the role of SIVA1 as a mediator for modulating p53
activities remains ill-defined. Collectively, as (i) ES increases
p53 phosphorylation (Fukuda et al., 2013), (ii) p53 differential
expression is observed in cellular proliferation (Dazard et al.,
2000; Ohkubo et al., 2006), and (iii) SIVA1 enhances p53
degradation, we hypothesized that ES can accelerate the rate
of re-epithelialization through its ability to modulate p53 in a
SIVA1-dependent manner and subsequently increase
proliferation. Therefore, the aim of this study was to
determine whether SIVA1 modulation of p53 expression
drives keratinocyte proliferation during normal cutaneous
healing and whether ES drives this proregenerative response
in healing human skin. Our results showed that increased
expression of SIVA1 significantly modulates p53 activities and
enhances keratinocyte proliferation during ES.
RESULTS
ES preserves epidermal integrity in ex vivo human organ culture
tissue
To determine the role of ES in human cutaneous repair, an
ex vivo donut-shaped wound healing model was developed.
Here, human skin tissues (n¼10) were collected and
‘‘wounded’’ using a standardized punch biopsy (full-thickness
wounds; 4 mm wound inside an 8 mm tissue biopsy;
Supplementary Materials and Methods online). Tissues were
divided into three categories: (i) non-ES treated (control), (ii)
direct current treated (monophasic ES treatment (Sebastian
et al., 2011a); Supplementary Figure S1a online), and (iii)
degenerate wave (DW) treated (biphasic ES treatment
(Sebastian et al., 2011b); Supplementary Figure S1b;
Supplementary Materials and Methods online). Both categories
subjected to ES were exposed to 100 mV mm 1 of electric
field for 30 min every day for 16 days (Supplementary Figure
S2a online). The applied electric field was similar to the
endogenous ‘‘current of injury’’ prevailing during the initiation
of granulation tissue formation and wound contraction, further
leading to innate wound closure (Nuccitelli et al., 2008, 2011).
Matrigel was added to the center of the explants, as
mammalian cell growth has been previously reported in this
three-dimensional basement membrane gel (Muthuswamy
et al., 2001; Supplementary Figure S2b online). Cell viability
within cultured explants over the period examined in this study
was confirmed using mitochondrial lactate dehydrogenase
release assay. This assay did not show any significant increase
in cell death until beyond day 16 in the cultured tissues
compared with baseline values (Supplementary Figure S2c
online). Progression of healing between groups was compared
on days 6 and 16 (Figure 1a and Supplementary Figure S2a
online). ES treatment accelerated tissue ingrowth into the
wound center compared with the control explants in our
ex vivo model (Supplementary Figure S2d online). To further
explore the ability of ES to maintain epidermal stratification
and integrity over 16 days, cytokeratin 10 immunohistochem-
istry was performed (Figure 1b). Cytokeratin 10 stains supra-
basal epidermal layers, and it is one of the preliminary proteins
to be detected when keratinocytes commit to differentiate
(Patel et al., 2006; Lamb and Ambler, 2013). mRNA transcript
quantification of cytokeratin 10 and the epidermal thickness
measurements showed a significant increase (P¼0.001 and
P¼ 0.006, respectively) on day 16 ES explants compared with
day 16 control explants (Figure 1c and d). The results indicated
the potential advantage of electric fields in maintaining the
epidermal integrity of the wounded explants.
ES upregulates PCNA, HDM2, and SIVA1 in the epidermis of
ex vivo–cultured human skin explants
To test the hypothesis that ES promotes keratinocyte prolifera-
tion, which is known to contribute to both epidermal main-
tenance and re-epithelialization through its ability to modulate
p53 activity, we examined the expression of proliferating cell
nuclear antigen (PCNA), phospho-p53, HDM2, and SIVA1 in
the wounded human explants exposed to exogenous electric
field. A significant upregulation (Po0.05) of PCNA on day 16
in ES explants was seen, predominantly within the stratum
basale of the epidermis, compared with day 16 of control
explants (Figure 2a and b, Supplementary Figure S3a and b
online). Here, a stable expression of phospho-p53 was observed
in stratum basale despite elevated proliferation levels (Figure 2a
and c, Supplementary Figure S3c and d online). HDM2 showed
significant overexpression (Po0.05) in ES explants compared
with controls on day 16 (Figure 2a and d, Supplementary Figure
S3e and f online). HDM2 was present in the stratum spinosum
and the stratum basale in normal human skin epidermis on day
0 (Supplementary Figure S3e online). However, HDM2 was
confined only to the stratum basale in the control explants on
day 16, while it was also expressed in the suprabasal layers of
the ES explants similar to normal skin on day 0. This differential
localization of HDM2 expression on day 16 suggests a
supportive role for ES in keratinocyte differentiation and
maintenance of normal epidermal architecture. Significant
upregulation (Po0.05) of SIVA1 was also observed on day 16
in ES explants compared with control explants (Figure 2a and e,
Supplementary Figure S3g and h online). SIVA1 was also
expressed predominantly in the stratum basale of the epidermis,
similar to PCNA, phospho-p53, and HDM2.
ES upregulates PCNA, HDM2, and SIVA1 in human
keratinocytes in vitro, and promotes physical interaction of
phospho-p53 with SIVA1
We further investigated the expression of PCNA, phospho-
p53, HDM2, and SIVA1 at the cellular level following ES. For
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this, we subjected a monolayer of human primary keratino-
cytes to similar electric field for 1 h and assessed the mRNA
transcripts by quantitative real-time reverse-transcriptase–PCR.
We observed a significant increase (Po0.05) in mRNA
transcripts of SIVA1 and PCNA (nearly twofold and threefold
increase, respectively) in keratinocytes subjected to ES com-
pared with non-ES-treated keratinocytes (Supplementary
Figure S4a online). In addition, protein analysis also confirmed
significant upregulation of PCNA, HDM2, and SIVA1 (Po0.05
compared with control explants; Figure 3a and b), but with a
stable expression of phospho-p53 post ES (P40.05). Taking
together the mRNA and the protein results, the in vitro ES
conditions could maintain p53 levels, but with a significant
increase of SIVA1. Here, similar to the explant study,
keratinocyte proliferation was increased with a coincident
significant increase in SIVA1 induction.
Next, we looked for any physical interaction between
phospho-p53 and SIVA1 post ES. Endogenous phospho-p53
was immunoprecipitated by an anti-SIVA1 antibody but not by
a control antibody and reciprocally, which showed an
enhanced interaction between phospho-p53 and SIVA1 post
ES (Figure 3c).
Loss of SIVA1 augments the antiproliferative activity of p53 post
ES
Next, we investigated the role of SIVA1 in augmenting
keratinocyte proliferation. For this, we transfected primary
human keratinocytes with single-interference RNA for SIVA1
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Figure 1. Maintainence of human skin explants in tissue culture. (a) Within the limited exposure to electrical stimulation (ES; 100 mVmm 1 every day for 30 min),
ES explants had partial dermal wound closure compared with control explants, on day 16. (b) Immunohistochemical analysis of cytokeratin 10 on day 0 and day 16
explants, with and without ES. (c) Messenger RNA (mRNA) transcript quantification of cytokeratin 10. There was nearly a threefold increase in mRNA expression of
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(Supplementary Figure S4b and c online) and subsequently
applied ES. Here, loss of SIVA1 expression in keratinocytes
post ES induced higher mRNA expression of p53 and HDM2
compared with non-ES-treated keratinocytes (Po0.05;
Supplementary Figure S4d online). Although the decline in
mRNA expression of PCNA in SIVA siRNA-treated keratino-
cytes post ES was nonsignificant compared with controls
(P40.05; Supplementary Figure S4d online), protein analysis
showed a significant decrease (Po0.05) in PCNA expression
(Figure 3d and e). HDM2 protein expression was also
significantly upregulated (Po0.05) in siRNA-transfected kera-
tinocytes post ES compared with control; however, the
antiproliferative effect of enhanced phospho-p53 was evident
after ES treatment (Figure 3d and e). This shows decreased
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Western blotting showed upregulation of proliferating cell nuclear antigen (PCNA), human double minute 2 (HDM2), and SIVA1 expression post ES. (b)
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intensities in d showed the upregulation of HDM2 and downregulation of proliferation in keratinocytes subjected to ‘SIVA1 siRNA transfectionþ ES’ compared
with siRNA-transfected keratinocytes. (f) Fold change in messengerRNA expression of ‘keratinocytesþ ES’, ‘keratinocytesþ SIVA1 siRNA’, and
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degradation efficiency of HDM2 or increased transcriptional
activity of phospho-p53 in keratinocytes subjected to ES in the
absence of SIVA1. This suggests that HDM2-modulated
activities of p53 in wound healing, such as proliferation of
human keratinocytes, is largely a SIVA1-dependent process.
Phospho-p53 accumulates more in the cell nucleus post ES in
SIVA1 knocked-down keratinocytes
Having established that downregulation of SIVA1 expression
could both significantly increase p53 and decrease PCNA
expression, we investigated whether ES could also induce
differential intracellular localization of phospho-p53, HDM2,
and SIVA1. Generally, p53 shuttles between the cytoplasm
and the nucleus, which is controlled by several mechanisms
including potential transactivation, protein stability, and
ubiquitination processes (O’Brate and Giannakakou, 2003).
In wild-type keratinocytes, SIVA1 was rarely detected as a
nuclear protein; however, weak cytoplasmic localization was
observed (Figure 4a). ES (DW) significantly increased phos-
pho-p53 and SIVA1 expression levels in the cytoplasm
(Figure 4a). Interestingly, here, SIVA1 was also expressed in
the nucleus where a near absence of phospho-p53 was
observed. However, loss of SIVA1 induced an increase in
nuclear expression and a slight decrease in the cytoplasmic
expression of phospho-p53 in keratinocytes post ES. In addi-
tion, an increase in phospho-p53 levels was also evident from
the protein analysis of nuclear lysates post ES (Figure 4b).
In wild-type keratinocytes, HDM2 was mainly localized in
the cytoplasm. This suggests degradation of cytoplasmic
phospho-p53 in wild-type keratinocytes under normal
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conditions by coordinated HDM2 and SIVA1 interaction. After
ES, HDM2 was strongly induced in both the nucleus and the
cytoplasm of keratinocytes (Figure 4c). When correlated to
phospho-p53 cellular localization post ES, this suggests pro-
teosomal degradation of nuclear phospho-p53 by combined
HDM2 and SIVA1 interaction. In SIVA1-deficient keratino-
cytes post ES, an upregulation of both nuclear and cytoplasmic
HDM2 was observed. Here, when correlated to phospho-p53
cellular localization post ‘SIVA1 knock downþ ES’, the
decrease in cytoplasmic phospho-p53 degradation could
largely be because of HDM2 alone (if any), but this was
totally unseen in the nucleus. The increased nuclear localiza-
tion of phospho-p53 could also be because of nuclear import
of phospho-p53 (Liang and Clarke, 1999). However,
HDM2 alone was unable to decrease nuclear phospho-p53
levels. Collectively, the in vitro staining suggests (i)
cytoplasmic degradation of phospho-p53 under normal
conditions by HDM2 and SIVA1, (ii) enhanced degradation
of nuclear phospho-p53 by HDM2-SIVA1 coexpression post
ES, and (iii) significant decrease in the ability to degrade
nuclear phospho-p53 by HDM2 alone in the absence of
SIVA1, post ES.
SIVA1 modulates cell cycle progression of primary keratinocytes
post ES
Given the known role of p53 activation on cell cycle
progression and apoptosis (Chen et al., 1994), we
investigated the role of SIVA1 in p53-dependent modulation
of keratinocyte cell cycle in wound healing electric fields.
Here, propidium iodide staining for DNA content was
performed. Compared with wild-type keratinocytes (non-ES
treated), DW ES significantly increased S phase population
(P¼ 0.0037; Figure 4d); however, attenuation in S phase was
not observed. In addition, there was only a mild increase
(P40.05) in G2/M phase, which indicated the possibility for
further initiation of cellular differentiation. Collectively,
wound healing electric field of 100 mV/mm may increase
DNA synthesis with a likely representation of DNA replication
rather than DNA repair in human primary keratinocytes. In
SIVA1 knocked-down keratinocytes post ES, sub-G1 popula-
tion was significantly increased when compared with wild-
type keratinocytes and ‘wild-type keratinocytesþDW ES’
(P¼ 0.0004). Here, G1 and S phase cells were significantly
decreased (P¼ 0.0044 and P¼0.008, respectively). This
statistically significant increase in sub-G1 post ‘SIVA1
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knockdownþ ES’ indicated a gradual transition of the prolif-
erating cells in G2/M population to potential cell death. These
data support a role for SIVA1 in modulating the antiprolifera-
tive and proapoptotic effect of p53 in human keratinocytes
post ES.
ES increases epidermal proliferation in vivo in human cutaneous
healing wounds
To further characterize the in vivo role of SIVA1 in modulating
keratinocyte proliferation in response to exogenous ES during
human skin repair, we examined phospho-p53 /HDM2/SIVA1
expression in biopsies from volunteers (n¼ 20) undergoing
normal healing (non-ES treated) and ES-assisted healing (DW
ES treatment; Supplementary Figure S5; Supplementary
Materials and Methods online). After establishing that ES
upregulated proliferation within the epidermis of human
explants ex vivo, we investigated temporal induction of
proliferation within the epidermis during both normal and
ES-assisted wound healing processes (Figure 5a and
Supplementary Figure S6a online). As anticipated, keratino-
cyte proliferation in ES-treated wounds was higher compared
with non-ES-treated wounds throughout the healing process
(until day 10). Although proliferation peaked on day 3 in both
ES and non-ES-treated wounds (as evidenced by the percen-
tage of cells stained positive for PCNA in Figure 5a), ES
treatment increased cellular proliferation by 19 and 38% on
healing days 3 and 7, respectively (P¼0.002 for ES treatment
day 7 versus normal skin healing day 7). In addition, the
number of epidermal cells were significantly higher in ES-
treated wounds on both healing days 3 (increase ofB62%,
P¼0.001) and 7 (increase ofB27%, P¼0.02) compared with
normal healing wounds (Supplementary Figure S6b online).
Consistent with this finding, the thickness of healing epithe-
lium was also slightly higher (P40.05) in ES-treated wounds
compared with non-ES-treated wounds (increment of nearly
B18% on day 3 andB11% on day 7, respectively;
Supplementary Figure S6c online).
ES treatment increases p53–SIVA1 colocalization in vivo
Next, in order to define SIVA1-mediated p53 modulation by
HDM2 in vivo, colocalization of phospho-p53, HDM2, and
SIVA1 was investigated. Specifically, we examined the colo-
calization of (i) phospho-p53–SIVA1 and (ii) HDM2-SIVA1 by
double immunolabeling the neo-epidermis (Supplementary
Figure S7a and b online, respectively). In both normal and
ES-treated healing processes, the percentage of cells stained
positive for phospho-p53 and SIVA1 were increased until day
7 and decreased on further days (Figure 5b). Notably, there
was a significant increase in SIVA1 expression on days 3 and 7
in ES-treated wounds compared with non-ES-treated wounds
(increment ofB34%, P¼0.009 and increment ofB41%,
P¼0.004, respectively, on days 3 and 7; Figure 5b). The
colocalization of phospho-p53–SIVA1 and HDM2-SIVA1 was
at its highest on day 3 for both the healing mechanisms (ES
treated and non-ES treated), which correlated to the highest
proliferation rate on day 3 when compared with subsequent
wound healing days (Figure 5c). However, the colocalization
of phospho-p53–SIVA1 was significantly higher in ES-treated
wounds on day 7 compared with non-ES-treated wounds (ES
treatment day 7:normal skin healing day 7¼34%, P¼0.001).
Consistent with the role of ES in upregulating SIVA1 during
cutaneous healing, the observed increment in the colocaliza-
tion of phospho-p53–SIVA1 in ES-treated wounds has shown
to enhance proliferation on day 7. HDM2-SIVA1 temporal
coexpression was also similar to phospho-p53–SIVA1 coex-
pression on the respective healing days, with no significant
difference between the ES-treated and the non-ES-treated
wounds. This validates the known role of HDM2 in modulat-
ing p53 along with SIVA1. Taking together proliferation and
phospho-p53-HDM2-SIVA1 coexpression during ES, we sug-
gest that SIVA1 may also have a critical role to enhance
in vivo proliferative mechanisms in association with HDM2,
but without p53 degradation, as previously reported (Ohkubo
et al., 2006).
DISCUSSION
In this study, we showed that exogenous ES can effectively
maintain epidermal integrity ex vivo and enhance prolifera-
tion/SIVA1 expression in keratinocytes while maintaining the
level of p53. Our in vitro results were consistent with ex vivo
results; however, loss of SIVA1 in keratinocytes resulted in an
increase of p53 and attenuation of proliferation post ES.
Finally, a significant increase in the coexpression of phos-
pho-p53–SIVA1, and proliferation during ES-assisted wound
healing in human epidermis, was shown in our in vivo healing
data. Collectively, our findings identified that SIVA1 was
upregulated in vitro, ex vivo, and in vivo post ES application
and that the enhanced SIVA1 modulated p53 activities with-
out p53 degradation.
In normal conditions, SIVA1 promotes p53-HDM2 complex
interaction and enhances HDM2-mediated p53 ubiquitination
and degradation (Du et al., 2010). However, when cells are
subjected to DNA damage, this ternary complex is broken
down and p53 is stabilized (Mei and Wu, 2012). However,
few studies indicate an inhibition of upregulated p53 activities
by enhanced HDM2 protein levels (Chen et al., 1994). Even
though both HDM2 and phospho-p53 were upregulated
following SIVA1 knock down in keratinocytes, the
degradation-promoting effect of HDM2 alone on p53 in
physiological wound healing is questionable.
Chen et al. (1994) has shown the inability of cells to arrest
in G1 phase following overexposure of HDM2 as it
downregulates p53. Accordingly, in SIVA1 knocked down
cells, HDM2 was unable to decrease p53 post-ES and
consequently G1 population was decreased, which is also in
accordance with Flatt et al. (1998). Our observations on
inefficient p53 regulation by HDM2 alone is further
strengthened by increased nuclear localization of phospho-
p53 post ES in the absence of SIVA1. After ES, SIVA1 and
HDM2 were expressed in the nucleus, where an absence of
phospho-p53 was observed, indicating successful p53
degradation. Here, cytoplasmic localization of phospho-p53
was also detected in the presence of HDM2 and SIVA1,
supporting different mechanisms of p53 accumulation and
degradation in nuclear and cytoplasmic segments (O’Brate
and Giannakakou, 2003).
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Endogenous phospho-p53 was increased until day 7 in
human cutaneous wound healing. However, phospho-p53–
SIVA1 coexpression was reduced on day 7 compared with
day 3, which indicated the stabilization of p53. The intensity
of this dissociation was greater in normal healing (non-ES-
treated wounds), which reflected the diminished prolifera-
tion rate on day 7 relative to ES-treated wounds. When
correlated to in vitro ES results, the observed upregulation of
SIVA1 in ES-treated wounds on day 7 might have augmented
the increased interaction between phospho-p53, HDM2,
and SIVA. However, here, phospho-p53 expression was
not decreased. Albeit there was an increase in SIVA1 and
HDM2 post ES, the decreased interaction of phospho-p53–
SIVA1-HDM2 on day 7 compared with day 3 opens the
discussion on whether the primary role of ES is to sustain the
association between phospho-p53–SIVA1-HDM2 molecules
(ternary complex) rather than increasing the number of
ternary complexes. In one of the studies, downstream targets
of p53 were significantly impaired by an overexpression of
HDM2 without affecting p53 protein levels (Ohkubo et al.,
2006). Here, a promoter-selective effect on p53 activity at
the transcriptional level was exhibited by HDM2. From our
in vivo coexpression studies, it is highly possible that
involvement of SIVA1 in the ternary complex enhances
this transcriptional repression mediated by HDM2, leading
to an increase in proliferation. This also is the closest
possibility to demonstrate physiologically enhanced
proliferation with simultaneously higher HDM2 and SIVA1
levels (Figure 5d).
Exogenous application of ES could be an efficient strategy to
maintain the physiological properties in an in vivo wound
environment or to deliver additional current to the wound to
enhance the healing process, especially when endogenous
wound current is disturbed owing to injury or concurrent
pathology. By comparing ES strategies (direct current and
DW), we suggest that electrical waveforms may be able to
drive supra-physiological responses to accelerate wound
healing. In summary, the results presented here signify the
presence of wound electric fields in maintaining the integrity
of the epidermis and the critical role of SIVA1 in regulating
p53 activities in human epithelial repair.
MATERIALS AND METHODS
Patient selection and recruitment
This study was conducted in accordance with the ethical principles of
Good Clinical Practice and the Declaration of Helsinki Principles. For
both human skin explant (ex vivo; n¼ 10; Supplementary Table S1a
online) and human ES studies (in vivo; n¼ 20; Supplementary Table
S1b online), we received ethical approval from the local research
committee (Manchester, UK), and all subjects gave full written,
informed consent.
ES device used on human volunteers
The ES device used for in vivo ES-assisted wound healing studies was
the Fenzian system (Fenzian, Hungerford, UK), which is registered by
the Food and Drug Administration 510(k) and approved by Con-
formite Europenne. ES methodology adopted on human volunteers is
detailed in Supplementary Materials and Methods online.
Establishment of primary keratinocytes
Primary keratinocytes were isolated from normal skin tissues obtained
from abdominoplasties. Detailed methodology is provided in
Supplementary Materials and Methods online.
Preparation of human skin explants, maintenance of organ
culture as air-exposed in collagen gel matrix, and separation of
the epidermis from the dermis in human explants
The normal skin tissues obtained from abdominoplasties were
processed to design wound explants. Detailed methodology is
provided in Supplementary Materials and Methods online.
In vitro ES apparatus and application
A simple and precise apparatus for ES was designed for monolayer of
cells and tissues (Sebastian et al., 2011a). Detailed methodology is
provided in Supplementary Materials and Methods online.
Tissue preparation for wax embedding, sectioning, and
hematoxylin and eosin staining
Explants for wax embedding were fixed in 10% neutral-buffered
formalin (F5304; Sigma-Aldrich, Dorset, UK) at 41C for 3–4 days and
processed as described previously (Sebastian et al., 2011b). Further
explanation of the methodology is provided in Supplementary
Materials and Methods online.
RNA isolation, cDNA synthesis, and quantitative real-time
reverse-transcriptase–PCR
Keratinocytes were processed for RNA isolation, cDNA synthesis, and
quantitative real-time reverse-transcriptase–PCR, as described pre-
viously (Sebastian et al., 2011a). Further explanation of the
methodology is provided in Supplementary Materials and Methods
online. The primers used are detailed in Supplementary Table S2
online.
Immunohistochemistry, immunocytochemistry, and image
analysis
Immunohistochemical and immunocytochemical staining were per-
formed as detailed in our previous reports (Sebastian et al., 2011a;
Sebastian et al., 2011b). Further explanation of the methodology is
detailed in Supplementary Materials and Methods online. Antibodies
and incubation parameters are detailed in Supplementary Table S3
online. The stained slides were scanned and images were analyzed
on the Definiens Immunohistochemistry software (Definiens tissue
studio version 3.51, Definiens AK, Munchen, Germany) to quantify
the results.
Coimmunoprecipitation, western blotting, and band analysis
Coimmunoprecipitation of phospho-p53 and SIVA1 and
protein analysis of whole-cell and nuclear lysates of primary
keratinocytes and human explant epidermis by western blotting are
detailed in Supplementary Materials and Methods online. Antibodies
and incubation parameters are detailed in Supplementary Table S4
online.
siRNA gene knockdown
Ambion siRNA target online tool (Silencer Pre-Designed and Vali-
dated siRNAs) was used to select siRNA sequences that target human
SIVA1 siRNA (s20746; Ambion, Austin, TX). Further methodology is
provided in Supplementary Materials and Methods online.
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Flow cytometry
Flow cytometry analysis of primary keratinocytes post ES is provided
in Supplementary Materials and Methods online.
Lactate dehydrogenase cytotoxicity assay
Lactate dehydrogenase assay was performed according to the man-
ufacturer’s instructions (11644793001; Cytotoxicity Detection Kit,
Roche Mannheim, Sandhofer Strae, Germany). The end point
absorbance of the samples was measured at 490 and 600 nm using
a microplate reader.
Statistical analysis
Data are presented as mean± SD from three independent experi-
ments performed in triplicate (n¼ 3). Statistical analysis was calcu-
lated using one-way analysis of variance for comparison between
three groups with Tukey’s post hoc test and Student’s t test for
comparison between two groups. Confidence intervals of 95% with a
corresponding P-value of 0.05 were chosen throughout the analysis.
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